2021 Revenues ($USD) : $1,120,700,000
2021 R&D spend : not available
2021 Number of Employees : 5,000
Fiscal Year End : 12/31/2020
Key People : Matthew Trerotola, president and CEO; Christopher Hix, EVP and CFO; Shyam Kambeyanda, CEO, ESAB and Colfax EVP; Brady Shirley, CEO, DJO and Colfax EVP; Larry Coble, SVP, Colfax business system and supply chain; Daniel Pryor, EVP, strategy and business development; Patricia Lang, SVP, chief human resources officer; Bradley Tandy, SVP, general counsel and corporate secretary.

About the company: Colfax plans to split into two publicly traded companies early next year — with businesses including DJO forming a new stand-alone orthopedic device company called Enovis that will be headquartered in Wilmington, Delaware, with a significant presence in the Dallas area. Current Colfax CEO Matt Trerotol will lead the medtech business, with Colfax EVP Brady Shirley serving as COO. The company over the summer announced the acquisition of Mathys AG Bettlach and its products for artificial joint replacement, synthetic bone graft solutions and sports medicine. Stryker in 2020 sold its total ankle replacements and finger joint implants businesses to Colfax/DJO to appease antitrust regulators as part of Stryker’s merger with Wright Medical. –CN